Cargando…
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
BACKGROUND: To assess whether whole-body (WB) bone SPECT/CT provides additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence (PC-BR). METHODS: Patients referred for a PC-BR and whom benefited from a WB bone...
Autores principales: | de Leiris, Nicolas, Leenhardt, Julien, Boussat, Bastien, Montemagno, Christopher, Seiller, Alexandre, Phan Sy, Olivier, Roux, Julie, Laramas, Mathieu, Verry, Camille, Iriart, Carole, Fiard, Gaelle, Long, Jean-Alexandre, Descotes, Jean-Luc, Vuillez, Jean-Philippe, Riou, Laurent, Djaileb, Loïc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425051/ https://www.ncbi.nlm.nih.gov/pubmed/32787923 http://dx.doi.org/10.1186/s40644-020-00333-y |
Ejemplares similares
-
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
por: Montemagno, Christopher, et al.
Publicado: (2019) -
How we read FCH-PET/CT for prostate cancer
por: Beauregard, Jean-Mathieu, et al.
Publicado: (2016) -
Development and Validation of Analytical Methods for Radiochemical Purity of (177)Lu-PSMA-1
por: Orhon, Pauline, et al.
Publicado: (2022) -
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019) -
Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
por: Liu, Shuang, et al.
Publicado: (2023)